相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy
Karl-Ludwig Schaefer et al.
EUROPEAN JOURNAL OF CANCER (2008)
Quantitative, spatial resolution of the epigenetic field effect in prostate cancer
Jyoti Mehrotra et al.
PROSTATE (2008)
Quantitative multi-gene expression profiling of primary prostate cancer
Uta Schmidt et al.
PROSTATE (2006)
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
Lawrence True et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling
M Scaltriti et al.
CARCINOGENESIS (2006)
The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer
Hideaki Miyake et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Molecular diagnosis of human cancer type by gene expression profiles and independent component analysis
XW Zhang et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/ml: Observation and clinical implications from Tyrol screening project
AE Pelzer et al.
UROLOGY (2005)
Colon cancer prognosis prediction by gene expression profiling
A Barrier et al.
ONCOGENE (2005)
Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate
H Uetsuki et al.
JOURNAL OF UROLOGY (2005)
Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies
R Montironi et al.
BJU INTERNATIONAL (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
UR Chandran et al.
BMC CANCER (2005)
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
M Gleave et al.
WORLD JOURNAL OF UROLOGY (2005)
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia
C Crescioli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells
M Scaltriti et al.
CANCER RESEARCH (2004)
Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report
MR Pins et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
DD3PCA3 RNA analysis in urine -: A new perspective for detecting prostate cancer
M Tinzl et al.
EUROPEAN UROLOGY (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression
A Caporali et al.
CARCINOGENESIS (2004)
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer
M Scaltriti et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent
TG Chen et al.
CANCER RESEARCH (2004)
A comparative study of feature selection and multiclass classification methods for tissue classification based on gene expression
T Li et al.
BIOINFORMATICS (2004)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog
C Crescioli et al.
ENDOCRINOLOGY (2003)
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression
S Bettuzzi et al.
ONCOGENE (2002)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy
LV July et al.
PROSTATE (2002)
Comparison of discrimination methods for the classification of tumors using gene expression data
S Dudoit et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia
WA Sakr et al.
UROLOGY (2001)
Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment
S Astancolle et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death
CR Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
